#USA #Veeva Systems #Barcelona #Medtech Companies #Postmarket Quality

A New Era for Medtech Quality Management

A recent study conducted by Veeva Systems, documented in their 2025 MedTech Postmarket Quality Benchmark Report, shows a clear trend in the medical technology sector. A remarkable 88% of the surveyed medtech companies are prioritizing the modernization of postmarket quality management within the next three years. This shift not only highlights the industry's focus on improving compliance and innovation but also signals a significant departure from outdated practices.

Understanding the Current Landscape

Despite the overwhelming majority planning advancements, the report indicates that about 68% of these companies still rely heavily on manual processing systems. Many use a combination of outdated paper and electronic systems or depend on legacy on-premise solutions. This reliance can stem from several challenges, including the complexity of transitioning to new technologies and fear of disruptions in compliance and operations. Slow response times to patient safety concerns can lead to severe repercussions, affecting compliance, detracting from consumer trust, and tarnishing brand reputation.

According to the study, organizations that are hesitant to modernize often face backlogs in complaint handling and delays in addressing product issues. Moreover, the consequences of slow responses can be dire, potentially hampering patient safety initiatives and overall market trust in the brands involved.

Key Drivers of Change

The report highlights several motivating factors behind this move to enhance postmarket quality management:
1. Proactive Quality Management: A proactive, risk-based quality management system is seen as the cornerstone of future success, with 38% of respondents indicating that this is a primary driver.
2. Scaling Processes: Approximately 26% noted that scaling operations to adapt to ever-changing market demands is crucial for sustained growth.
3. Technology Integration: A significant 75% of surveyed companies believe advanced technology can facilitate automation for faster timelines and greater efficiency. Additionally, 62% think that integrating these technologies with quality management systems could streamline operations.

Despite this optimism, the adoption of advanced technologies, such as generative AI and robotic process automation, remains disappointing, with less than 3% of medtechs implementing these innovations effectively. However, the study reflects a positive outlook on the potential benefits, with improving timeliness and efficiency recognized as prime opportunities awaiting those who embrace new technologies.

Challenges Ahead

The research also identifies significant gaps in employee training, emphasizing that only 19% of respondents find their training programs adequate to support postmarket quality teams effectively. This lack of sufficient training highlights the importance of interactive learning approaches, enabling workers to receive real-time updates and necessary guidance on their roles in quality management.

According to Vishaka Rajaram, the Senior Director of Quality Strategy at Veeva MedTech, many organizations are limited by legacy systems and existing manual processes. Aligning modern technology with strategic goals will empower medtechs to transition from reactive issue management to proactive risk prevention. This shift will lead to expedited processes, compliance, and the overall health of the industry.

The Bigger Picture

The 2025 Veeva MedTech Postmarket Quality Benchmark Report canvassed over 100 quality leaders within the medtech industry, highlighting the progress, challenges, and vast opportunities present in the realm of quality management. As the medical device and diagnostic industries evolve, understanding these dynamics will be essential for stakeholders aiming for success.

To explore the full depth of the study and learn more about the changing landscape of medtech quality management, access the comprehensive benchmark report here.

With the imminent modernization efforts set in motion, the future of medtech looks not only innovative but also significantly committed to creating safer and more reliable medical technologies.